Marc F. Pelletier, Ph.D.

Marc is the host of Futures in Biotech, which debuted on TWiT.TV in June 2006.

Marc received his Ph.D. in Biology from McGill University, in Montreal, Canada in 2002, and completed 6 years of post-doctoral research at the Yale School of Medicine in the Departments of Genetics, Molecular Biophysics and Biochemistry, and Cellular and Molecular Physiology. Marc then co-founded and is currently Chief Scientific Officer of Aeromics, a biotechnology company that is developing drugs to treat cerebral edema, or brain swelling, which occurs after stroke and traumatic brain injury.

Marc F. Pelletier, Ph.D.
stdClass Object ( [nid] => 9769 [type] => person [language] => [uid] => 34590 [status] => 1 [created] => 1315329328 [changed] => 1315329328 [comment] => 0 [promote] => 0 [moderate] => 0 [sticky] => 0 [tnid] => 0 [translate] => 0 [vid] => 9769 [revision_uid] => 34590 [title] => Marc F. Pelletier, Ph.D. [body] => Marc is the host of Futures in Biotech, which debuted on TWiT.TV in June 2006. Marc received his Ph.D. in Biology from McGill University, in Montreal, Canada in 2002, and completed 6 years of post-doctoral research at the Yale School of Medicine in the Departments of Genetics, Molecular Biophysics and Biochemistry, and Cellular and Molecular Physiology. Marc then co-founded and is currently Chief Scientific Officer of Aeromics, a biotechnology company that is developing drugs to treat cerebral edema, or brain swelling, which occurs after stroke and traumatic brain injury. [teaser] => Marc is the host of Futures in Biotech, which debuted on TWiT.TV in June 2006. Marc received his Ph.D. in Biology from McGill University, in Montreal, Canada in 2002, and completed 6 years of post-doctoral research at the Yale School of Medicine in the Departments of Genetics, Molecular Biophysics and Biochemistry, and Cellular and Molecular Physiology. Marc then co-founded and is currently Chief Scientific Officer of Aeromics, a biotechnology company that is developing drugs to treat cerebral edema, or brain swelling, which occurs after stroke and traumatic brain injury. [log] => [revision_timestamp] => 1315329328 [format] => 1 [name] => colin [picture] => [data] => a:3:{s:13:"form_build_id";s:37:"form-05929576ae2dfbec3f808c3cd5d47527";s:14:"picture_delete";i:1;s:14:"picture_upload";s:0:"";} [path] => people/marc-f-pelletier-phd [field_profile_picture] => Array ( [0] => Array ( [fid] => 781 [uid] => 34590 [filename] => pelletier.jpg [filepath] => files/pelletier_0.jpg [filemime] => image/jpeg [filesize] => 6561 [status] => 1 [timestamp] => 1315329322 [list] => 1 [data] => Array ( [alt] => [title] => ) ) ) [field_user_account] => Array ( [0] => Array ( [uid] => ) ) [field_teaser] => Array ( [0] => Array ( [value] => Host, "Futures in Biotech" [format] => 1 ) ) [field_links] => Array ( [0] => Array ( [url] => [title] => [attributes] => ) ) [subscriptions_notify] => 1 [taxonomy] => Array ( [117] => stdClass Object ( [tid] => 117 [vid] => 5 [name] => Hosts [description] => [weight] => 0 [v_weight_unused] => 0 ) ) [files] => Array ( ) [0] => [channel] => Array ( ) [premiere] => 0 [remnant] => 0 [probability] => 100 [radioactivity] => Array ( [energy] => Array ( [1] => 1.6495966247192 ) ) [uuid] => [revision_uuid] => )

Primary links